{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:16:22Z","timestamp":1790954182399,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"DOI":"10.7759\/cureus.26856","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T18:39:51Z","timestamp":1657823991000},"source":"Crossref","is-referenced-by-count":6,"title":["Therapeutic Efficacy of Botulinum Toxin in Trigeminal Neuralgia"],"prefix":"10.7759","author":[{"given":"Abdul Mueez Alam","family":"Kayani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minollie Suzanne","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleesha","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malay","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Karnakoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X17666191010094350","article-title":"Trigeminal neuralgia: basic and clinical aspects","volume":"18","author":"Araya EI","year":"2020","unstructured":"Araya EI, Claudino RF, Piovesan EJ, Chichorro JG. Trigeminal neuralgia: basic and clinical aspects. Curr Neuropharmacol. 2020, 18:109-19. 10.2174\/1570159X17666191010094350","journal-title":"Curr Neuropharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2015.2.20140501","article-title":"Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options","volume":"20","author":"Al-Quliti KW","year":"2015","unstructured":"Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options. Neurosciences (Riyadh). 2015, 20:107-14. 10.17712\/nsj.2015.2.20140501","journal-title":"Neurosciences (Riyadh)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall GC","year":"2008","unstructured":"Hall GC, Carroll D, McQuay HJ. Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005. BMC Fam Pract. 2008, 9:26. 10.1186\/1471-2296-9-26","journal-title":"BMC Fam Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1744806920901890","article-title":"Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments","volume":"16","author":"Gambeta E","year":"2020","unstructured":"Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments. Mol Pain. 2020, 16:1744806920901890. 10.1177\/1744806920901890","journal-title":"Mol Pain"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39085.614792.BE","article-title":"Trigeminal neuralgia and its management","volume":"334","author":"Bennetto L","year":"2007","unstructured":"Bennetto L, Patel NK, Fuller G. Trigeminal neuralgia and its management. BMJ. 2007, 334:201-5. 10.1136\/bmj.39085.614792.BE","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.12.2347","article-title":"Trigeminal neuralgia: pathology and pathogenesis","volume":"124","author":"Love S","year":"2001","unstructured":"Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001, 124:2347-60. 10.1093\/brain\/124.12.2347","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002782","article-title":"Trigeminal neuralgia: a practical guide","volume":"21","author":"Lambru G","year":"2021","unstructured":"Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol. 2021, 21:392-402. 10.1136\/practneurol-2020-002782","journal-title":"Pract Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/0333102416687280","article-title":"Trigeminal neuralgia - diagnosis and treatment","volume":"37","author":"Maarbjerg S","year":"2017","unstructured":"Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017, 37:648-57. 10.1177\/0333102416687280","journal-title":"Cephalalgia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub2","article-title":"Carbamazepine for acute and chronic pain in adults","volume":"1","author":"Wiffen PJ","year":"2011","unstructured":"Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev. 2011, 1:CD005451. 10.1002\/14651858.CD005451.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0023-0","article-title":"Refractory trigeminal neuralgia. Non-surgical treatment options","volume":"27","author":"Cruccu G","year":"2013","unstructured":"Cruccu G, Truini A. Refractory trigeminal neuralgia. Non-surgical treatment options. CNS Drugs. 2013, 27:91-6. 10.1007\/s40263-012-0023-0","journal-title":"CNS Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e31821a07b7","article-title":"Microvascular decompression treatment for trigeminal neuralgia","volume":"22","author":"Chakravarthi PS","year":"2011","unstructured":"Chakravarthi PS, Ghanta R, Kattimani V. Microvascular decompression treatment for trigeminal neuralgia. J Craniofac Surg. 2011, 22:894-8. 10.1097\/SCS.0b013e31821a07b7","journal-title":"J Craniofac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-011-1026-1","article-title":"Computed tomography-guided \u03b3 knife stereotactic radiosurgery for trigeminal neuralgia","volume":"153","author":"Park KJ","year":"2011","unstructured":"Park KJ, Kano H, Berkowitz O, Awan NR, Flickinger JC, Lunsford LD, Kondziolka D. Computed tomography-guided \u03b3 knife stereotactic radiosurgery for trigeminal neuralgia. Acta Neurochir (Wien). 2011, 153:1601-9. 10.1007\/s00701-011-1026-1","journal-title":"Acta Neurochir (Wien)"},{"key":"ref13","article-title":"Treatment of trigeminal neuralgia by percutaneous radiofrequency rhizotomy","volume":"8","author":"Taha JM","year":"1997","unstructured":"Taha JM, Tew JM Jr. Treatment of trigeminal neuralgia by percutaneous radiofrequency rhizotomy. Neurosurg Clin N Am. 1997, 8:31-9.","journal-title":"Neurosurg Clin N Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.10.049","article-title":"A nationwide study of three invasive treatments for trigeminal neuralgia","volume":"152","author":"Koopman JS","year":"2011","unstructured":"Koopman JS, de Vries LM, Dieleman JP, Huygen FJ, Stricker BH, Sturkenboom MC. A nationwide study of three invasive treatments for trigeminal neuralgia. Pain. 2011, 152:507-13. 10.1016\/j.pain.2010.10.049","journal-title":"Pain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S331036","article-title":"Trigeminal neuralgia: current approaches and emerging interventions","volume":"14","author":"Xu R","year":"2021","unstructured":"Xu R, Xie ME, Jackson CM. Trigeminal neuralgia: current approaches and emerging interventions. J Pain Res. 2021, 14:3437-63. 10.2147\/JPR.S331036","journal-title":"J Pain Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5037\/jomr.2020.11202","article-title":"The use of botulinum toxin A in the management of trigeminal neuralgia: a systematic literature review","volume":"11","author":"Rubis A","year":"2020","unstructured":"Rubis A, Juodzbalys G. The use of botulinum toxin A in the management of trigeminal neuralgia: a systematic literature review. J Oral Maxillofac Res. 2020, 11:e2. 10.5037\/jomr.2020.11202","journal-title":"J Oral Maxillofac Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2019.1620795","article-title":"The role of botulinum toxin in the treatment of strabismus","volume":"34","author":"Escuder AG","year":"2019","unstructured":"Escuder AG, Hunter DG. The role of botulinum toxin in the treatment of strabismus. Semin Ophthalmol. 2019, 34:198-204. 10.1080\/08820538.2019.1620795","journal-title":"Semin Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.60343","article-title":"Botulinum toxin","volume":"55","author":"Nigam PK","year":"2010","unstructured":"Nigam PK, Nigam A. Botulinum toxin. Indian J Dermatol. 2010, 55:8-14. 10.4103\/0019-5154.60343","journal-title":"Indian J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000370245","article-title":"Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin","volume":"95","author":"Yiannakopoulou E","year":"2015","unstructured":"Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015, 95:65-9. 10.1159\/000370245","journal-title":"Pharmacology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12575","article-title":"Delayed hypersensitivity reaction to onabotulinumtoxinA","volume":"5","author":"LeWitt PA","year":"2018","unstructured":"LeWitt PA. Delayed hypersensitivity reaction to onabotulinumtoxinA. Mov Disord Clin Pract. 2018, 5:321-2. 10.1002\/mdc3.12575","journal-title":"Mov Disord Clin Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008133","article-title":"Botulinum toxin in the treatment of trigeminal neuralgia: 6-month follow-up","volume":"96","author":"T\u00fcrk B\u00f6r\u00fc \u00dc","year":"2017","unstructured":"T\u00fcrk B\u00f6r\u00fc \u00dc, Duman A, B\u00f6l\u00fck C, Co\u015fkun Duman S, Ta\u015fdemir M. Botulinum toxin in the treatment of trigeminal neuralgia: 6-month follow-up. Medicine (Baltimore). 2017, 96:e8133. 10.1097\/MD.0000000000008133","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7988","article-title":"Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: a follow-up retrospective study of 152 patients","volume":"18","author":"Zhang H","year":"2019","unstructured":"Zhang H, Lian Y, Xie N, Cheng X, Chen C, Xu H, Zheng Y. Factors affecting the therapeutic effect of botulinum toxin A on trigeminal neuralgia: a follow-up retrospective study of 152 patients. Exp Ther Med. 2019, 18:3375-82. 10.3892\/etm.2019.7988","journal-title":"Exp Ther Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-43","article-title":"Therapeutic effect of botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up","volume":"15","author":"Li S","year":"2014","unstructured":"Li S, Lian YJ, Chen Y, et al.. Therapeutic effect of botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up. J Headache Pain. 2014, 15:43. 10.1186\/1129-2377-15-43","journal-title":"J Headache Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-92","article-title":"Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?","volume":"14","author":"Shehata HS","year":"2013","unstructured":"Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?. J Headache Pain. 2013, 14:92. 10.1186\/1129-2377-14-92","journal-title":"J Headache Pain"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-65","article-title":"Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Zhang H","year":"2014","unstructured":"Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain. 2014, 15:65. 10.1186\/1129-2377-15-65","journal-title":"J Headache Pain"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/jnrp.jnrp_346_17","article-title":"Efficacy of botulinum toxin type A in trigeminal neuralgia in a South Asian cohort","volume":"9","author":"Caldera MC","year":"2018","unstructured":"Caldera MC, Senanayake SJ, Perera SP, Perera NN, Gamage R, Gooneratne IK. Efficacy of botulinum toxin type A in trigeminal neuralgia in a South Asian cohort. J Neurosci Rural Pract. 2018, 9:100-5. 10.4103\/jnrp.jnrp_346_17","journal-title":"J Neurosci Rural Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7365148","article-title":"Efficacy and safety of botulinum toxin type A in treating patients of advanced age with idiopathic trigeminal neuralgia","volume":"2018","author":"Liu J","year":"2018","unstructured":"Liu J, Xu YY, Zhang QL, Luo WF. Efficacy and safety of botulinum toxin type A in treating patients of advanced age with idiopathic trigeminal neuralgia. Pain Res Manag. 2018, 2018:7365148. 10.1155\/2018\/7365148","journal-title":"Pain Res Manag"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S205467","article-title":"Botulinum toxin type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect","volume":"12","author":"Wu S","year":"2019","unstructured":"Wu S, Lian Y, Zhang H, et al.. Botulinum toxin type A for refractory trigeminal neuralgia in older patients: a better therapeutic effect. J Pain Res. 2019, 12:2177-86. 10.2147\/JPR.S205467","journal-title":"J Pain Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0793-3","article-title":"Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study","volume":"18","author":"Zhang H","year":"2017","unstructured":"Zhang H, Lian Y, Xie N, Chen C, Zheng Y. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study. J Headache Pain. 2017, 18:81. 10.1186\/s10194-017-0793-3","journal-title":"J Headache Pain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/head.13608","article-title":"Pilot study of injection of onabotulinumtoxinA toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia","volume":"59","author":"Crespi J","year":"2019","unstructured":"Crespi J, Bratbak D, Dodick DW, Matharu M, Jamt\u00f8y KA, Tronvik E. Pilot study of injection of onabotulinumtoxinA toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia. Headache. 2019, 59:1229-39. 10.1111\/head.13608","journal-title":"Headache"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/648384","article-title":"Application of purified botulinum type a neurotoxin to treat experimental trigeminal neuropathy in rats and patients with urinary incontinence and prostatic hyperplasia","volume":"2012","author":"Matsuka Y","year":"2012","unstructured":"Matsuka Y, Yokoyama T, Yamamoto Y, et al.. Application of purified botulinum type a neurotoxin to treat experimental trigeminal neuropathy in rats and patients with urinary incontinence and prostatic hyperplasia. J Toxicol. 2012, 2012:648384. 10.1155\/2012\/648384","journal-title":"J Toxicol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01254-2","article-title":"Unilateral facial injection of botulinum neurotoxin a attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice","volume":"22","author":"Chen WJ","year":"2021","unstructured":"Chen WJ, Niu JQ, Chen YT, et al.. Unilateral facial injection of botulinum neurotoxin a attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice. J Headache Pain. 2021, 22:38. 10.1186\/s10194-021-01254-2","journal-title":"J Headache Pain"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/toxins13100704","article-title":"Peripherally administered botulinum toxin type a localizes bilaterally in trigeminal ganglia of animal model","volume":"13","author":"Waskitho A","year":"2021","unstructured":"Waskitho A, Yamamoto Y, Raman S, et al.. Peripherally administered botulinum toxin type a localizes bilaterally in trigeminal ganglia of animal model. Toxins (Basel). 2021, 13:704. 10.3390\/toxins13100704","journal-title":"Toxins (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7083127","article-title":"Botulinum toxin for neuropathic pain: a review of the literature","volume":"7","author":"Oh HM","year":"2015","unstructured":"Oh HM, Chung ME. Botulinum toxin for neuropathic pain: a review of the literature. Toxins (Basel). 2015, 7:3127-54. 10.3390\/toxins7083127","journal-title":"Toxins (Basel)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.05.026","article-title":"A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia","volume":"123","author":"Moore D","year":"2019","unstructured":"Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. Br J Anaesth. 2019, 123:e385-96. 10.1016\/j.bja.2019.05.026","journal-title":"Br J Anaesth"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S168650","article-title":"Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis","volume":"11","author":"Meng F","year":"2018","unstructured":"Meng F, Peng K, Yang JP, Ji FH, Xia F, Meng XW. Botulinum toxin-A for the treatment of neuralgia: a systematic review and meta-analysis. J Pain Res. 2018, 11:2343-51. 10.2147\/JPR.S168650","journal-title":"J Pain Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/toxins9090260","article-title":"Botulinum toxin for the treatment of neuropathic pain","volume":"9","author":"Park J","year":"2017","unstructured":"Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017, 9:260. 10.3390\/toxins9090260","journal-title":"Toxins (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/104847-therapeutic-efficacy-of-botulinum-toxin-in-trigeminal-neuralgia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:08Z","timestamp":1707507908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/104847-therapeutic-efficacy-of-botulinum-toxin-in-trigeminal-neuralgia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.26856","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}